Hepatocellular carcinoma caused by loss of heterozygosity in Lkb1 gene knockout mice

Cancer Research

Volumn 62, Issue 16, 2002, Pages 4549-4553

  Nakau, Masayuki ^a   Miyoshi, Hiroyuki ^a,b   Seldin, Michael F ^c   Imamura, Masayuki ^a   Oshima, Masanobu ^a   Taketo, Makoto M ^a  

^a KYOTO UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CELL DIVISION; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; HETEROZYGOSITY LOSS; HISTOLOGY; INTESTINE POLYP; KNOCKOUT MOUSE; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PEUTZ JEGHERS SYNDROME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEX DIFFERENCE; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CELL DIVISION; LIVER NEOPLASMS, EXPERIMENTAL; LOSS OF HETEROZYGOSITY; MICE; MICE, KNOCKOUT; PROTEIN-SERINE-THREONINE KINASES;

EID: 0037102428     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Increased risk of cancer in the Peutz-Jeghers syndrome
2. Cancer and the Peutz-Jeghers syndrome
3. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome
4. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase
5. Growth suppression by Lkb1 is mediated by a G cell cycle arrest
6. LKB1, a novel serine/threonine protein kinase and potential tumour suppressor, is phosphorylated by cAMP-dependent protein kinase (PKA) and prenylated in vivo
7. 433, is essential for LKB1 to suppress cell growth
8. LKB1 associates with Brg1 and is necessary for Brg1-induced growth arrest
9. The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death
10. Vascular abnormalities and deregulation of VEGF in Lkb1-deficient mice
11. Gastrointestinal hamartomatous polyposis in Lkb1 heterozygous knockout mice
12. Transgenic animals as models for hepatocarcinogenesis
13. Hepatic pathology of genetically engineered mice
14. Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice
15. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis
16. Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice
17. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-α
18. Ploidy and karyotypic alterations associated with early events in the development of hepatocarcinogenesis in transgenic mice harboring c-myc and transforming growth factor α transgenes
19. Disruption of the pRB/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor α
20. STK11 mutations in Peutz-Jeghers syndrome and sporadic colon cancer
21. Pathogenesis of adenocarcinoma in Peutz-Jeghers syndrome
22. Molecular genetic alterations in hamartomatous polyps and carcinomas of patients with Peutz-Jeghers syndrome
23. LIP1, a cytoplasmic protein functionally linked to the Peutz-Jeghers syndrome kinase LKB1
24. Role of growth factors and cytokines in hepatic regeneration
25. TGF-β signal transduction
26. Acceleration of c-myc-induced hepatocarcinogenesis by co-expression of transforming growth factor (TGF)-α in transgenic mice is associated with TGF-β1 signaling disruption
27. Heterozygous mice for the transforming growth factor-β type II receptor gene have increased susceptibility to hepatocellular carcinogenesis
28. Hepatocellular expression of a dominant-negative mutant TGF-β type II receptor accelerated chemically induced hepatocarcinogenesis